IPQ Inside the global regulatory dialogue

Emerging Technology Approvals Among FDA Office of Pharmaceutical Quality’s First-Year Achievements

Feb 21st, 2016

Please Log in to print the full article

Driving Better First-Cycle Approval Rates A comparison of the two user fee acts shows the potential for GDUFA to increase generic drug first-cycle approval rates, Yu pointed out. PDUFA, he noted, has allowed the agency...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications